ONEHEALTH Commercial Readiness Workshop: Turning Innovation into Opportunity

A great idea can be the starting point for innovation. But turning that idea into a commercially viable opportunity means asking some important and sometimes difficult questions. Who is your paying customer? Who makes the purchasing decision? And how do you know there's a genuine willingness to pay?

These were some of the questions explored at our recent ONEHEALTH Commercial Readiness Workshop, which brought participants together for a day of practical learning, discussion and insights into the commercialisation journey.

Facilitated by ONEHEALTH Innovation Brokers Toni O'Neill and Tomas Bamford, the workshop encouraged participants to look beyond their technology and consider the commercial opportunities and challenges facing their innovations.

Learning from Experience

One of the highlights of the day was a fireside chat with Fiona Bennington and Dan Ferguson, Founder of Axial3D, who shared first-hand experiences of developing, commercialising and growing innovative businesses.

We also welcomed Professor John Breslin from the University of Galway, who led a session on commercial model essentials, encouraging participants to think carefully about their target markets, customers and routes to market.

A key message emerged throughout the discussions: find your paying customer early.

Understanding who will use a product is only part of the picture. Innovators also need to identify who influences purchasing decisions, who controls the budget and who ultimately signs off on a purchase.

Participants were encouraged to ask these questions early, alongside exploring customer budgets, purchasing processes and sales cycles, to better understand whether their ideas represent viable commercial opportunities.

Proof Before Product

Another important takeaway was the value of proof before product.

Through primary market research, innovators can test their assumptions, understand customer needs and establish whether there is a genuine willingness to pay for their proposed solution.

The discussions also highlighted the importance of focusing on a clearly defined target market and recognising that early customer conversations can offer more than research insights.

The people engaged during market research could become future customers, making these conversations an important first step in building relationships and developing a potential sales pipeline.

Supporting the Commercialisation Journey

Throughout the day, participants were encouraged to step back from the technology itself and consider a fundamental question: what needs to be true for someone to buy this?

A big thank you to Fiona, Dan and John for sharing their experience and expertise, to Toni and Tomas for facilitating the workshop, and to everyone who contributed to the discussions.

For ONEHEALTH, developing commercial readiness alongside technical innovation is an important part of supporting SMEs to turn promising ideas into real-world impact.

Interested in joining ONEHEALTH?

Applications for ONEHEALTH AI Accelerator Cycle 2 are now open, offering SMEs the opportunity to access specialist AI expertise and innovation support.

https://www.onehealthproject.co/ai-accelerator

ONEHEALTH is a project supported by PEACEPLUS, a programme managed by the Special EU Programmes Body (SEUPB)

Previous
Previous

Celebrating Innovation: ONEHEALTH Accelerator SMEs Recognised for Success

Next
Next

One Health Day 2026: Connecting Health, Research and Innovation